Abstract No. 146 ▪ Featured Abstract Safety of Selective Transarterial Radioembolization for Hepatocellular Carcinoma in Patients with Baseline Hyperbilirubinemia

Hyperbilirubinemia co-occurs in patients with cirrhosis and hepatocellular carcinoma (HCC) and is often considered a contraindication to Yttrium-90 trans-arterial radioembolization (TARE). We hypothesize that selective TARE is safe in patients with HCC and baseline hyperbilirubinemia.

Source: Journal of Vascular and Interventional Radiology : JVIR - February 21, 2024 Category: Radiology Authors: M. Serhal, A. Gabr, P. Entezari, A. Riaz, L. Kulik, A. Kalyan, A. Gordon, R. Salem, R. Lewandowski Source Type: research